chrisvoncsefalvay/vaers-outcomes huggingface dataset:
faster/quicker heartbeat; my heart beating double what it was supposed to be; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEART RATE INCREASED (faster/quicker heartbeat) and TACHYCARDIA (my heart beating double what it was supposed to be) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 026B21A) for COVID-19 vaccination.     No Medical History Reported.  Concomitant products included METFORMIN, LISINOPRIL and EMPAGLIFLOZIN (JARDIANCE) for Diabetes, LEVOTHYROXINE for Thyroid disorder, COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (faster/quicker heartbeat) (seriousness criterion medically significant) and TACHYCARDIA (my heart beating double what it was supposed to be) (seriousness criterion medically significant). The patient was treated with RIVAROXABAN (XARELTO) ongoing since an unknown date for Anticoagulant therapy, at a dose of 20 mg once a day and METOPROLOL SUCCINATE ongoing since an unknown date for Heart disorder, at a dose of 25 mg once a day. At the time of the report, HEART RATE INCREASED (faster/quicker heartbeat) and TACHYCARDIA (my heart beating double what it was supposed to be) outcome was unknown.            Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.   Very limited information regarding the events has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding the events has been provided at this time.  Further information has been requested.
Client states she felt dizzy 15 minutes after she received her vaccines, stated dizziness last for 2 to 3 minutes, denied any other.  symptoms, fruit juice provided to client, client stated she felt better. client discharged home with parent.
Nurse gave patient his 3 rd dose of Pfizer. She realized after giving the dose she gave too much. She gave 0.5ml instead of 0.3ml. Patient was informed about the dosage. Also the staff called the Health Officer  about the error. Patient was upset. Dr. did call the patient to reassure. I also called the patient today to get information & see how he was doing. He stated that  he was really tired. No other issues.
Site of administration bled after administered. A few hours after admin, pt felt lethargic and had cold sweats. Next morning, pt vomited. Pt also reports red rash and severe soreness at site of administration 3 days after admin.
Have extreme allergic reactions; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 79-year-old female patient received pneumococcal 20-val conj vac (dipht crm197 protein) (PREVNAR 20), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history included: "allergic to mercury" (unspecified if ongoing); "allergic to soy" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: HYPERSENSITIVITY (non-serious), outcome "unknown", described as "Have extreme allergic reactions".  Additional information: The patient stated that she has extreme allergic reactions. By recommendation of pharmacist and doctor, the patient was questioning the Prevnar 20 ingredients. The patient was allergic to soy and mercury, so was asking if Prevnar has these.   The information on the batch/lot number for pneumococcal 20-val conj vac (dipht crm197 protein), pneumococcal 20-val conj vac (dipht crm197 protein)  has been requested and will be submitted if and when received.
This spontaneous report was received from a nurse and refers to an unspecified, multiple patients of an unknown age and gender. The patients' pertinent medical history, concomitant medications and drug reaction or allergies were not reported. On an unspecified dates, the patients were vaccinated with improperly stored doses of ROTATEQ lot # R013288, expiration date 01-DEC-2019 (exact strength, doses, frequency and route of administration were not reported) administered for prophylaxis. The doses of ROTATEQ were stored at the temperature of 32 degrees Fahrenheit to 35 degrees Fahrenheit for 48 hours. There were no previous temperature excursions reported. The call was because of data logger. No adverse effects were reported. The outcome of product storage error and no adverse event was unknown.
Rapid resting heartrate (108 average) beginning 3 hours  after injection (1 pm) and lasting  4-5 hours then slowly returned to normal (65-70) over the next 3 hours (by 9 pm). There were also accompanying heart palpitations. No shortness of breath or chest pain. I had already been experiencing some palpitations and raised heartrate on occasion, and suspected my thyroid medication is too high. I had contacted my doctor to lower my dose. But never had my heart raced that fast for that long and while resting. I also read that Cayenne can increase heartrate and I did drink some added to my juice that morning.
Approximately 1 hour after receiving vaccine, patient reported fatigue, chills, headache, muscle pain, joint pain, slight nausea and injection site (right deltoid) pain, mild swelling and warm to the touch.  Temp 97.9, HR 82, B/P 130/84, RR 16.  At 1800, patient went home and will follow-up with our onsite Nurse if needed.
Localized induration at site in left deltoid measuring 4cm, red and warm but not particularly tender. No streaking. Also has significant PPD reaction.
Information has been received from a Registered Nurse concerning a patient who was vaccinated with all three doses of MMR II. The patient's antibody response to the vaccine was negative even after getting all three doses. Unspecified medical attention was sought. Additional information has been requested.
Stomach ache with loose stools four hours after vaccination. No fever. Woke up today with no stomach ache, but continues with loose stools (light).
Difficulty breathing, pain/heaviness/congestion in chest, chills, headache, severe headache, feeling miserable, right arm pain.
pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (pregnant) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00SC21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for an unknown indication.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 26-Jan-2021 and the estimated date of delivery was 17-Oct-2021. On 06-May-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fourteenth week of the pregnancy.  On 06-May-2021, MATERNAL EXPOSURE DURING PREGNANCY (pregnant) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
On April 18, 2022 she started to have chest pain, cold and chest congestion, memory loss. I took the patient to the Emergency Hospital and she tested positive for COVID-19. They instructed me to give her Tylenol.
Had area that was red and tender. Measured 14cm x 11 1/2cm.
Information has been received from a LPN concerning a 5 year old "F" student with no medical history and no allergies who on 04/26/96 was vaccinated SC with a first dose of varicella virus vaccine Live (Lot # 616868/1653B). There was no illness at the time of vaccination. At a recent visit to the physician's office the mother stated that in April 1998 her daughter developed a varicella-like rash. It was noted that they were not sure of all the details. The mother also reported that the child developed chickenpox following exposure to another unvaccinated sibling who had developed chickenpox after being exposed to the disease in school. The nurse noted that their office had no record of this event and could offer no further information on the matter. No medical attention was sought. No diagnostic tests were performed. Subsequently the pt recovered. No product quality complaint was involved. No further information is expected. It was also reported that the pt's sibling was vaccinated with a dose of varicella virus vaccine live and developed chickenpox (WAES # 0307USA01111).
I received the booster and two weeks later I begin to feel swelling on the same side of the injection site on my neck and shoulder,  I went to my primary care physician 02/08/2022 we agreed to a CAT scan but swelling subsided before it was performed.  Since the swelling has subsided difficulty walking and standing has increased.
about 2 hours after vaccine - pt experienced swelling in the arm of vaccine all the way down to elbow and up her neck as well.  Pt also had intense pain in the arm along with fever as well. pt had a rash on arm also.
This spontaneous report was received from a registered pharmacist concerning a 68 years old female patient with no pertinent medical history or drug reactions/allergies who on 15-SEP-2012 was vaccinated with a dose of ZOSTAVAX, 0.65 mL, subcutaneously (lot # 0364AE, expiration date on 16-MAR-2016). Concomitant therapy included FLUZONE. On 18-SEP-2012, the patient developed an egg size welt at the injection site "for 5 days". On an unspecified date, the patient developed a low grade fever that never was over 101F for "3-4 days". The patient was treated with TYLENOL for the fever and ice on the injection site if needed. No laboratory tests were performed. The patient called the pharmacist. The pharmacist stated that the patient's egg size welt at the injection site was getting better every day. At the time of the report, the event outcome for egg size welt a the injection site was recovering and the event outcome for low grade fever was unknown. The relatedness for had an egg size welt at the injection site and low grade fever was unknown for ZOSTAVAX. Additional information has been requested.
Acute fine sandpapery-vesicular-eruption on L biceps about 9 inches away from IM site where received flu shot. No fever. Non toxic. Labs unremarkable.
I had soreness in the left arm for @ 2 days after the vaccination.  No redness, no swelling.   After that, no known problem.  Exactly one week after the injection, On the morning of Tuesday, January 5, 2021, I noticed soreness in my left arm similar to what I had right after the injection. It was painful to extend my arm over my head.  Later that day, I noticed a small 1 3/4" x 1" area of redness and warmth appearing at or right next to the area of the injection.  Over the next 24-48 hours, the area grew and became swollen, more red, and warmer.  The soreness in my arm didn't seem to change at all; it was painful to lift my arm overhead and to touch.  The area grew to approximately 3" x 4" during that time period.  On Thursday morning, 1/7/21, my PCP, inspected the area and felt the swelling and the warmth.  She believed that I had likely developed cellulitis in the arm and placed me on cephalexin 500 mg, one capsule tid.  I began taking that on Thursday afternoon, 1/7/21.   By Friday evening, the area was barely visible, but was still warm and a little swollen.  It was still slightly tender. Today, Saturday, 1/9/21, the area is still a little warm and slightly swollen, but not visible at all, and there is only tenderness if I press on the area.
Mom says pt became irritable approx 1 1/2 hrs p/receiving immun; Also ran fever that night but did not check temp; Was irritable 24SEP & did not walk mom felt due to soreness & didn't want to walk; Also had a red, swollen area lt hip area;
Pt has a "knot" after 5th Anthrax vaccination, 6 months ago. "It is itchy, hard and solid". On a follow up report received 10/4/2000: Pt considers himself partially recovered, "lump on arm comes and goes".
This case was reported by a consumer and described the occurrence of cold virus in a 71-year-old female subject who was vaccinated with Influenza vaccine (unspecified) (manufacturer unspecified). A physician or other health care professional has not verified this report. The subject's medical history included thyroid resection. Concurrent medical conditions included asthma, chronic obstructive pulmonary disease and menopausal. Concurrent medications included MICARDIS. The subject has been on ADVAIR for 10 to 15 years now. Over the years, her blood pressure had steadily gotten higher without medication to control it. She thought the high blood pressure was also tied in with menopause. On an unspecified date, the subject received 1st dose of Influenza vaccine (unspecified) (intramuscular, administration site unknown, batch number not provided). 1 week after vaccination with Influenza vaccine (unspecified), the subject experienced cold virus. She took 1/2 of an ALKA SELTZER PLUS tablet and then could not breathe and could not talk. Moreover, the ALKA SELTZER was expired. The subject was hospitalised for 2 days. At the time of reporting, the events were resolved.
Had exposure prior to admission on 1/10/21. Had self quarantined due to this. Tested negative in community. Then had mental status change, went to hospital 1/18/21 and tested positive.
"Covid Arm." Itchy, red, patch about 5 inches in diameter at injection site. Started 9 days after shot. Getting better, treated with antihistamine cream.
Patient initially had an expected side effect of a sore upper right arm for 2-3 days post-injection, which then resolved.  This past Wednesday, Jan. 13, she developed redness, soreness, tenderness and warmth at the injection site.  She had no fever, but felt very tired and had body aches Jan. 14.   Nurse checked in with the patient today, Tuesday, Jan. 19, and she said these symptoms are improving with use of Benadryl. She notified her HCP of the concerns.
Extensive arthritis and arthralgias affecting all small joints of all 4 extremities as well as major joints of all 4 extremities and numerous sites along vertebrae.
death J18.9 - Pneumonia, unspecified organism N17.9 - Acute kidney failure, unspecified
Infant was administered Kinrix for DTap and IPV immunizations. Infant is 1 yr 1 mo old. Kinrix is licensed for 4 - 6 yrs .
Pt recvd 3rd dose of Hep B vax in SEP89 approx APR91 pt devel sx of fibromyalgia; No further details were provided;
5 minutes post felt light headed, had syncopal episode, diaphoretic, and pale. BP 80/50, HR 45 upon ED staff arrival. Patient vomiting undigested food.
brain fogginess is still persisting following the 1st shot; tiredness/no energy at all; Difficulty Breathing; Can't Seem to Wake-Up; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (Difficulty Breathing), HYPERSOMNIA (Can't Seem to Wake-Up), FEELING ABNORMAL (brain fogginess is still persisting following the 1st shot) and FATIGUE (tiredness/no energy at all) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event, Breast cancer, Heparin-induced thrombosis (Patient developed clot in one kidney.) and Splenic thrombosis. Concurrent medical conditions included Single functional kidney. Concomitant products included RIVAROXABAN (XARELTO) and LOSARTAN for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced DYSPNOEA (Difficulty Breathing) and HYPERSOMNIA (Can't Seem to Wake-Up). On an unknown date, the patient experienced FEELING ABNORMAL (brain fogginess is still persisting following the 1st shot) and FATIGUE (tiredness/no energy at all). At the time of the report, DYSPNOEA (Difficulty Breathing), FEELING ABNORMAL (brain fogginess is still persisting following the 1st shot) and FATIGUE (tiredness/no energy at all) had not resolved and HYPERSOMNIA (Can't Seem to Wake-Up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were provided. Concomitant medication include Serota.       Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Follow up was received Added events, patient relevant history, concomitant medication, events,Updated reporters contact information, event outcome.
Initial consumer report via call center received on 07 Dec 2009: This patient had received with H1N1 0.5 ml for Immunisation on 04 Dec 2009. The batch no was 102132P1. Just after three minutes of receiving vaccine, the patient started experiencing dizziness and her heart was racing. Within next three hours, the patient had swelling of her tongue and throat. The patient was rushed to emergency room, where she was treated for anaphylactic shock and discharged shortly after. At the time of report, the patient was feeling sick with shortness of breath and lightheadedness. Outcome of the events were ongoing. Follow up received from quality assurance department on 03 Feb 2010: Based on the evaluation of the concerned H1N1 batch 102132P1 (expiry date 31 Mar 2010), all tests related to the safety, sterility and efficacy were complied with the test specifications. Batch review could not conclude the reason for the reported adverse event based on data available.
COVID SYMPTOMS; COVID SYMPTOMS; Liver count was down; Hurt all over; FACILITATED COLLECT  This is a solicited report received from contactable reporter(s) (Consumer or other non HCP) for a sponsored program. The reporter is the patient. Other Case identifier(s): 22K-163-4265597-00 (Agency).  A 66 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administration date 20Jan2022 (Batch/Lot number: unknown) at the age of 65 years as dose 3 (booster), single, intramuscular, administration date 09May2021 (Batch/Lot number: unknown) as dose 2, single and intramuscular, administration date 18Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation; upadacitinib (RINVOQ), oral (Batch/Lot number: unknown) for rheumatoid arthritis. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "COVID SYMPTOMS"; LIVER FUNCTION TEST DECREASED (non-serious), outcome "unknown", described as "Liver count was down"; PAIN (non-serious), outcome "unknown", described as "Hurt all over". The patient underwent the following laboratory tests and procedures: liver function test: liver count was down. The action taken for upadacitinib was unknown.  Causality for RINVOQ(UPADACITINIB): The reporter's causality for the event(s) of liver count was down, covid symptoms and hurt all over was not provided.  Causality for PFIZER BIONTECH COVID-19 VACCINE(TOZINAMERAN). The reporter's causality for the event(s) of liver count was down, covid symptoms was not reported and hurt all over was possible.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: (Based on plausible dose -event relationship post vaccination and no other alternate explanation the causal role of BNT162B2 cannot be excluded for the reported LOE events and Decreased LFT, Pain.
Itchy skin on arms and upper back. Red welts Indigestion that lasted 5 hours.
positive Covid test the day before second dose of vaccine; positive Covid test the day before second dose of vaccine; This is a spontaneous report from a Pfizer-sponsored program, by  contactable physician reported for herself.  This 38-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot # EK5730), intramuscular at single dose in the left deltoid on 22Dec2020 11:00 for Covid-19 immunisation. Medical history included was none. There were no concomitant medications. The patient experienced positive Covid test the day before second dose of vaccine on 11Jan2021 with outcome of not recovered. On an unspecified date, she can't smell or taste and has some shortness of breath on exertion with outcome of unknown. No further treatments given. Did not have any antibody testing recently and had history of negative antibodies prior to everything, receiving the first vaccine. The vaccine was administered at Hospital Facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  The patient received first vaccine on 22Dec2020 and went for Covid testing on Saturday, 09Jan2021. Found out results were positive on 11Jan2021. She was scheduled to have the second Covid vaccine on 12Jan2021. Patient  then asks if there is a problem with her getting the second dose vaccine 10 days later than originally scheduled due to her results.; Sender's Comments: Based on available information, a possible contributory role of BNT162B2 cannot be completely excluded for reported "positive Covid test the day before second dose of vaccine".
Severe swelling of the leg, large rash covering leg and parts of body, fever >102 (symptoms became present within, or less than , one hour after vaccine was administered)  I called the on-call Nurse line to report the reaction. However, I do not think the nurse or anyone documented any of my safety concerns or the reaction. I asked the nurse to let the doctor know of the adverse reaction.  I do not believe that was done either.  I closely watched my daughter for the next 24 hours and the rash and extremely swollen leg began to clear. I believe a small dose of Benadryl was given to her.   I am still trying to resolve future vaccination alternatives not including pertussis vaccine.
Nausea, vomiting, body pain, headache, fatigue. eye crusting.
On Tuesday, March 30, 2021 a 47 year old male received his first doe of PFizer COVID19 vaccine (lot#-ER8727) at 3:550 PM at the school.  At 3:57 PM, the pt came to the Observation desk, and stated, "I don't feel right.  I feel like I'm going to pass out."  Observation crew assisted the pt to the chair.  The pt went completely "stiff".  The pt was caught by Observation crew and did not fall to the floor.  During this state, the pt had what sounded like snoring respirations. (Continued narrative on pg 3).
Intense muscle and bone pain, unable to stand due to pain on the bottom of feet, blisters on hands, bad headache, joint pain, weakness, dizziness, fatigue, confusion.
Employee health not initially presented with full immunization records. MMR provided due to documented need for 2nd dose. Discovered upon data entry that employee had received an initial dose 12/2021 at a previous employer